Syneos Health (SYNH) Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 9 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SYNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SYNH, but not buy additional shares or sell existing shares.
View SYNH analyst ratings or view top-rated stocks.

9 Wall Street analysts have issued 12-month price targets for Syneos Health's stock. Their SYNH share price forecasts range from $28.00 to $73.00. On average, they expect the company's share price to reach $47.63 in the next twelve months. This suggests a possible upside of 14.1% from the stock's current price.
View analysts price targets for SYNH or view top-rated stocks among Wall Street analysts.

Syneos Health's stock was trading at $36.68 on January 1st, 2023. Since then, SYNH stock has increased by 13.8% and is now trading at $41.75.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our SYNH earnings forecast.

Syneos Health, Inc. (NASDAQ:SYNH) posted its quarterly earnings results on Wednesday, November, 3rd. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. The business earned $1.35 billion during the quarter, compared to the consensus estimate of $1.34 billion. Syneos Health had a trailing twelve-month return on equity of 12.14% and a net margin of 2.74%. Syneos Health's quarterly revenue was up 22.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.93 earnings per share.

ETFs with the largest weight of Syneos Health (NASDAQ:SYNH) stock in their portfolio include First Trust Health Care AlphaDEX Fund (FXH), Invesco S&P MidCap 400 Pure Value ETF (RFV), First Trust Nasdaq Pharmaceuticals ETF (FTXH), AI Powered Equity ETF (AIEQ), Syntax Stratified MidCap ETF (SMDY), First Trust Mid Cap Value AlphaDEX Fund (FNK), Vanguard Small-Cap Growth ETF (VBK) and Humankind US Stock ETF (HKND).

322 employees have rated Syneos Health Chief Executive Officer Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Block (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC).

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Syneos Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.18%), Wellington Management Group LLP (7.27%), Clearbridge Investments LLC (4.02%), Barclays PLC (2.96%), State Street Corp (2.75%) and FMR LLC (2.68%). Insiders that own company stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Thomas H Lee Advisors, Llc and Tom Allen.
View institutional ownership trends.

Shares of SYNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SYNH stock can currently be purchased for approximately $41.75.

Syneos Health (NASDAQ:SYNH) has a market capitalization of $4.33 billion and generates $5.39 billion in revenue each year. The company earns $266.50 million in net income (profit) each year or $1.43 on an earnings per share basis.

The company employs 29,395 workers across the globe.

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The official website for the company is www.syneoshealth.com. The company can be reached via phone at (919) 876-9300, via email at investor.relations@syneoshealth.com, or via fax at 919-876-9360.